Seaport Diagnostics Overview

  • Founded

  • 2014

Founded
  • Status

  • Private

  • Employees

  • 14

Employees
  • Latest Deal Type

  • 2ndary - Private

  • Investors

  • 13

Seaport Diagnostics General Information

Description

Developer of DNA test kits designed to treat rare genetically inherited diseases. The company's kits leverage biological science and technology to provide people with access to information about their genes to make proactive and personalized choices that may impact their well-being, enabling users to be well-informed about their bodies and make informed decisions.

Contact Information

Website
www.seaportdx.com
Formerly Known As
Orig3n
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Other Healthcare Services
Primary Office
  • 27 Drydock Avenue
  • 3rd Floor
  • Boston, MA 02210
  • United States
+1 (800) 000-0000

Seaport Diagnostics Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Seaport Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Secondary Transaction - Private 00000 Completed Generating Revenue
7. Later Stage VC 09-Sep-2020 000.00 00000 Completed Generating Revenue
6. Debt - PPP 15-Apr-2020 00000 000.00 Completed Generating Revenue
5. Later Stage VC 08-Nov-2019 00000 000.00 Completed Generating Revenue
4. Early Stage VC (Series B) 11-Jul-2018 0000 000.00 00000 Completed Generating Revenue
3. Early Stage VC (Series A2) 27-Jun-2017 0000 000.00 0000 Completed Generating Revenue
2. Early Stage VC (Series A) 16-Dec-2015 $12.5M $15.6M 0000 Completed Generating Revenue
1. Early Stage VC (Series 1) 05-Feb-2015 $3.14M $3.14M 00.000 Completed Generating Revenue
To view Seaport Diagnostics’s complete valuation and funding history, request access »

Seaport Diagnostics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B 00,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Series A2 00,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Series A 11,372,211 $0.000100 6% $1.1 $1.1 1x $1.1 13.49%
Series 1 7,498,225 $0.000100 6% $0.42 $0.42 1x $0.42 8.89%
To view Seaport Diagnostics’s complete cap table history, request access »

Seaport Diagnostics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of DNA test kits designed to treat rare genetically inherited diseases. The company's kits leverage biological
Monitoring Equipment
Boston, MA
14 As of 2021
00000
000000 - 000 00000

000000

, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dol
0000000000 00000000
Austin, TX
000 As of 0000
00000
0.000 0000-00-00
00000000000 00000

00000

aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugia
0000 000000000
Paris, France
000 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Seaport Diagnostics Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Everly Health Venture Capital-Backed Austin, TX 000 00000 00000000000 00000
00000 Venture Capital-Backed Paris, France 000 00000 00000000000 00000
00000000 Venture Capital-Backed San Francisco, CA 00 00000 0000000000 00000
0000000 Formerly VC-backed Hartford, CT 00.000 000000&0 00.000
0000000 Venture Capital-Backed Toronto, Canada 00 000.00 00000 000.00
To view Seaport Diagnostics’s complete competitors history, request access »

Seaport Diagnostics Patents

  • 78

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 5

    Granted

  • 2

    Pending

  • 000

    Expiring in next 12 mo

Seaport Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-190053-S Transitional graphical user interface Active 07-Aug-2018
AU-2019232732-A1 Ipsc-derived cell compositions, and related systems and methods for cartilage repair Inactive 06-Mar-2018 000000000
CA-3093370-A1 Ipsc-derived cell compositions, and related systems and methods for cartilage repair Inactive 06-Mar-2018 000000000
EP-3761996-A1 Ipsc-derived cell compositions, and related systems and methods for cartilage repair Pending 06-Mar-2018 000000000
US-20210038651-A1 Ipsc-derived cell compositions, and related systems and methods for cartilage repair Pending 06-Mar-2018 A61K35/32
To view Seaport Diagnostics’s complete patent history, request access »

Seaport Diagnostics Executive Team (8)

Name Title Board Seat Contact Info
Robin Smith Co-Founder & Chief Executive Officer
Kate Blanchard Co-Founder & Chief Operating Officer
Scott Snyder Chief Marketing Officer
Michael Fang MD Chief Medical Officer
You’re viewing 4 of 8 executive team members. Get the full list »

Seaport Diagnostics Board Members (6)

Name Representing Role Since
Byron Smith Mountain Group Partners Board Member 000 0000
Clay Thorp Hatteras Venture Partners Board Member 000 0000
Dylan Dai Seaport Diagnostics Board Member 000 0000
Elona Baum DEFTA Partners Board Member 000 0000
Justin Xiang Ph.D Syno Capital Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Seaport Diagnostics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Seaport Diagnostics Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
DAOL Investment Venture Capital Minority 000 0000 000000 0
Sekhmet Ventures Venture Capital Minority 000 0000 000000 0
Alexandria Venture Investments Corporate Venture Capital Minority 000 0000 000000 0
Haitong International Securities Group Hedge Fund Minority 000 0000 000000 0
MMIC Investment Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »

Seaport Diagnostics Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 0000 01-Aug-2020 0000000000 Diagnostic Equipment
Interleukin Genetics 22-Nov-2017 Merger/Acquisition Diagnostic Equipment
To view Seaport Diagnostics’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Seaport Diagnostics Subsidiaries (1)

Company Name Industry Location Founded
00000000 000000000 Diagnostic Equipment Redwood City, CA 0000
To view Seaport Diagnostics’s complete subsidiaries history, request access »